Company
Bain Capital Life Sciences
Investments
| Company | Round | Date | Lead |
|---|---|---|---|
| Imperative Care, Inc. | Convertible Note | 2026-03-18 | |
| Apreo Health | Series B | 2025-08-07 | Lead |
| Merida Biosciences | Series A | 2025-04-09 | Lead |
| Abcuro | Series C | 2025-02-13 | |
| Timberlyne Therapeutics | Series A | 2025-01-10 | Lead |
| Angitia Biopharmaceuticals | Series C | 2024-12-11 | Lead |
| Kailera Therapeutics | Series A Funding | 2024-10-01 | Lead |
| Cardurion Pharmaceuticals | Series B Financing | 2024-07-16 | |
| Freenome | Funding | 2024-02-15 | |
| Aiolos Bio | Series A Funding | 2023-10-25 | Lead |
| Abcuro | Series B Financing | 2023-08-18 | Lead |
| Kyverna Therapeutics | Series B Extension | 2023-08-03 | |
| Alkeus Pharmaceuticals | Series B Financing | 2023-06-07 | Lead |
| Heartflow, Inc. | Series F Funding | 2023-04-06 | Lead |